Toxicity of corticosteroids and catecholamines for mice neuronal cell cultures: Role of preservatives

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 20, Issue 4, 2007, Pages 325-333

  Dani, Carlo ^a   Vestri, Valentina ^a   Bertini, Giovanna ^a   Pratesi, Simone ^a   Rubaltelli, Firmino F ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Catecholamines; Corticosteroids; Neurotoxicity; Preterm infants; Sulfites

Indexed keywords

CATECHOLAMINE; CORTICOSTEROID; DEXAMETHASONE SODIUM PHOSPHATE; DOBUTAMINE; DOPAMINE; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE SODIUM SUCCINATE; PRESERVATIVE; PROPIDIUM IODIDE; SULFITE; DEXAMETHASONE; GLUCOCORTICOID; METHYLPREDNISOLONE; SODIUM METABISULFITE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DAMAGE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; DRUG EXPOSURE; ENZYME RELEASE; EXTRACELLULAR FLUID; GLIA CELL; MOUSE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CYTOLOGY; DRUG EFFECT; GLIA; NERVE CELL; NEWBORN;

ANIMALS; ANIMALS, NEWBORN; CATECHOLAMINES; CELLS, CULTURED; DEXAMETHASONE; DOPAMINE; GLUCOCORTICOIDS; METHYLPREDNISOLONE; MICE; NEUROGLIA; NEURONS; PRESERVATIVES, PHARMACEUTICAL; SULFITES;

EID: 34347266566     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050701227992     Document Type: Article

References (57)

1. Halliday HL, Ehrenkranz RA, Doyle LW. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003;1:CD001146.
2. Halliday HL, Ehrenkranz RA, Doyle LW. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003;1:CD001145.
3. Halliday HL, Ehrenkranz RA, Doyle LW. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003;1:CD001144.
4. Doyle I, Davis P. Postnatal corticosteroids in preterm infants: Systematic review of effects on mortality and motor function. J Pediatr Child Health 2000;36:101-107.
5. Barrington KJ. The adverse neuro-developmental effects of postnatal steroids in the preterm infants: A systematic review of RCTs. BMC Pediatrics 2001;1:1-14.
6. Committee on Fetus and Newborn. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002;109:330-338.
7. Reist M, Marshall KA, Jenner P, Halliwell B. Toxic effects of sulfite in combination with peroxynitrite on neuronal cells. J Neurochem 1998;71:2431-2438.
8. Baud O, Ludenbach V, Evrard P, Gressens P. Neurotoxic effects of fluorinated glucocorticoid preparations on the developing mouse brain: Role of preservatives. Pediatr Res 2001;50:706-711.
9. André P, Thebaud B, Odievre MH, Razafimahefa H, Zupan V, Dehan M, Lacaze-Masmonteil T. Methylprednisolone, an alternative to dexamethasone in very premature infants at risk of chronic lung disease. Intensive Care Med 2000;26:1496-1500.
10. Braughler JM, Hall ED. Effects of multi-dose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degradation and energy metabolism. J Neurosurg 1984;59:290-295.
11. st hour after contusion injury. J Neurosurg 1982;18:320-327.
12. Daneyemez M, Kurt E, Cosar A, Yuce E, Ide T. Methylprednisolone and vitamin E therapy in perinatal hypoxic-ischemic brain damage. Neuroscience 1999;92:693-697.
13. Dani C, Bertini G, Pezzati M, Poggi C, Guerrini P, Martano C, Rubaltelli FF. Prophylactic ibuprofen for the prevention of intraventricular hemorrhage in preterm infants: A multicenter randomized study. Pediatrics 2005;115:1529-1535.
14. Rose K, Goldberg MP, Choi DW. Cytotoxicity in murine neocortical cell culture. In: Tyson CA, Frazier JM, editors. Methods in toxicology. San Diego, USA: Academic Press; 1993. pp 46-60.
15. Pellegrini-Giampietro DE, Cozzi A, Peruginelli F, Leonardi P, Meli E, Pellicciari R, Moroni F, 1-Amino-1,5-dicarboxylic acid and (S)-(+)- 2-(3′-carboxybicyclo[1.1.1]pentyl)-glycine, two mGlu1 receptor-preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischaemia. Eur J Neurosci 1999;11:3637-3647.
16. Koh JY, Choi DW. Quantitative determination of glutamate-mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Meth 1987;20:83-90.
17. Strasser U, Fischer G. Protection from neuronal damage induced by combined oxygen and glucose deprivation in organotypic hippocampal cultures by glutamate receptor antagonists. Brain Res 1995;687:167-174.
18. Abdel-Hamid KM, Tymianski M. Mechanisms and effects of intracellular calcium buffering on neuronal survival in organotypic hippocampal cultures exposed to anoxia/aglycemia or to excitotoxins. J Neurosci 1997;17:3538-3553.
19. Pringle AK, Iannotti F, Wilde GJC, Chad JE, Seeley PJ, Sundstrom LE. Neuroprotection by both NMDA and non-NMDA receptor antagonists in in vitro ischemia. Brain Res 1997;755:36-46.
20. Uno H, Lohmiller L, Thieme C, Kemnitz JW, Engle MJ, Roecker EB, Farrell PM. Brain damage induced by prenatal exposure to dexamethasone in fetal rhesus macaques. I. Hippocampus. Brain Res Dev Brain Res 1990;53:157-167.
21. Carlos RQ, Seidler FJ, Slotkin TA. Fetal dexamethasone exposure alters macromolecular characteristics of rat brain development: A critical period for regionally selective alterations? Teratology 1992;46:45-59.
22. Bian X, Seidler FJ, Slotkin TA. Effects of fetal dexamethasone exposure on postnatal control of cardiac adenylate cyclase: Beta-adrenergic receptor coupling to Gs regulatory protein. Teratology 1993;48:169-177.
23. Zysk G, Bruck W, Gerber J, Bruck Y, Prange HW, Nau R. Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J Neuropathol Exp Neurol 1996;55:722-728.
24. Behl C, Lezoualc'h F, Trapp T, Widmann M, Skutella T, Holsboer F. Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro. Endocrinology 1997;138:101-106.
25. Sapolsky RM. Stress, glucocorticoids, and damage to the nervous system: The current state of confusion. Stress 1996;1:1-19.
26. Baud O, Foix-L'Helias L, Kaminski M, Audibert F, Jarreau PH, Papiernik E, Huon C, Lepercq J, Dehan M, Lacaze-Masmonteil T. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999;341:1190-1196.
27. Spinillo A, Chiara A, Bergante C, Biancheri D, Fabiana D, Fazzi E. Obstetric risk factors and persistent increases in brain parenchymal echogenicity in preterm infants. BJOG 2004;111:913-918.
28. Leist M, Fava E, Montecucco C, Nicotera P. Peroxynitrite and nitric oxide donors induce neuronal apoptosis by eliciting autocrine excitotoxicity. Eur J Neurosci 1997;9:1488-1498.
29. Charles B, Schild P, Steer P, Cartwright D, Donovan T. Pharmacokinetics of dexamethasone following single-dose intravenous administration to extremely low birth weight infants. Dev Pharmacol Ther 1993;20:205-210.
30. Park CO. The effects of methylprednisolone on prevention of brain edema after experimental moderate diffuse brain injury in rats - comparison between dosage, injection time, and treatment methods. Yonsei Med J 1998;39:395-403.
31. Lammertse DP. Update on pharmaceutical trials in acute spinal cord injury. J Spinal Cord Med 2004;27:319-325.
32. Roberts I, Yates D, Sandercock P, Farrell B, Wasserberg J, Lomas G, Cottingham R, Svoboda P, Brayley N, Mazairac G, et al. CRASH trial collaborators. Effect of intravenous corticosteroids on death within 14 days in 10 008 adults with clinically significant head injury (MRC CRASH trial): Randomised placebo-controlled trial. Lancet 2004;364:1321-1328.
33. Alagarsamy S, Phillips M, Pappas T, Johnson KM. Dopamine neurotoxicity in cortical neurons. Drug Alcohol Depend 1997;48:105-111.
34. McLaughlin BA, Nelson D, Erecinska M, Chesselet MF. Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor. J Neurochem 1998;70:2406-2415.
35. Jacobsson SO, Fowler CJ. Dopamine and glutamate neurotoxicity in cultured chick telencephali cells: Effects of NMDA antagonists, antioxidants and MAO inhibitors. Neurochem Int 1999;34:49-62.
36. Jones DC, Gunasekar PG, Borowitz JL, Isom GE. Dopamine-induced apoptosis is mediated by oxidative stress and is enhanced by cyanide in differentiated PC12 cells. J Neurochem 2000;74:2296-2304.
37. Chiueh CC, Miyake H, Peng MT. Role of dopamine autoxidation, hydroxyl radical generation, and calcium overload in underlying mechanism involved in MPTP-induced parkinsonism. Adv Neurol 1993;60:251-258.
38. Hastings TG, Lewis DA, Zigmond MJ. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injection. Proc Natl Acad Sci USA 1996;93:1956-1961.
39. 3H]-dopamine: Impact of ascorbic acid and glutathione. J Neurochem 1994;63:1126-1132.
40. Ben-Shachar D, Zuk R, Glinka Y. Dopamine neurotoxicity: Inhibition of mitochondrial respiration. J Neurochem 1995;64:718-723.
41. Miyaguchi H, Kato I, Sano T, Sobajima H, Fujimoto S, Togari H. Dopamine penetrates to the central nervous system in developing rats. Pediatr Int 1999;41:363-368.
42. Seri I, Tulassay T, Kiszel J, Sulyok E, Ertl T, Bodis J, Csomor S. Effect of low-dose dopamine therapy on catecholamine values in cerebrospinal fluid in preterm neonates. J Pediatr 1984;105:489-491.
43. Padbury JF, Agata Y, Baylen BG, Ludlow JK, Polk DH, Habib DM, Martinez AM. Pharmacokinetics of dopamine in critically ill newborn infants. J Pediatr 1990;117:472-476.
44. Garris PA, Ciolkowski EL, Pastore P, Wightman, RM. Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J Neurosci 1994;14:6084-6093.
45. Clemens JA, Phebus LA. Dopamine depletion protects striatal neurons from ischemia-induced cell death. Life Sci 1988;42:707-713.
46. Buisson A, Callebert J, Mathieu E, Plotkine M, Boulu RG. Striatal protection induced by lesioning the substantia nigra of rats subjected to focal ischemia. J Neurochem 1992;59:1153-1157.
47. Thibeault DW. The precarious antioxidant defenses of the preterm infant. Am J Perinatol 2000;17:167-181.
48. Koksal N, Baytan B, Bayram Y, Nacarkucuk E. Risk factors for intraventricular haemorrhage in very low birth weight infants. Indian J Pediatr 2002;69:561-564.
49. Marlow ES, Hunt LP, Marlow N. Sensorineural hearing loss and prematurity. Arch Dis Child Fetal Neonatal Ed 2000;82:F141-144.
50. Filippi L, Cecchi A, Tronchin M, Dani C, Pezzati M, Seminara S, Gasperini S, Zammarchi E, Rubaltelli FF. Dopamine infusion and hypothyroxinaemia in very low birth weight preterm infants. Eur J Pediatr 2004;163:7-13.
51. DiSessa TG, Leitner M, Ti CC, Gluck L, Coen R, Friedman WF. The cardiovascular effects of dopamine in the severely asphyxiated neonate. J Pediatr 1981;99:772-776.
52. Bourchier D, Weston PJ. Randomised trial of dopamine compared with hydrocortisone for the treatment of hypotensive very low birth weight infants. Arch Dis Child Fetal Neonatal Ed 1997;76:F174-178.
53. Cioca DP, Watanabe N, Isobe M. Apoptosis of peripheral blood lymphocytes is induced by catecholamines. Jpn Heart J 2000;41:385-398.
54. Dostanic S, Servant N, Wang C, Chalifour LE. Chronic beta-adrenoreceptor stimulation in vivo decreased Bcl-2 and increased Bax expression but did not activate apoptotic pathways in mouse heart. Can J Physiol Pharmacol 2004;82:167-174.
55. Hegener O, Prenner L, Runkel F, Baader SL, Kappler J, Haberlein H. Dynamics of beta2-adrenergic receptor-ligand complexes on living cells. Biochemistry 2004;43:6190-6199.
56. Colangelo AM, Mallei A, Johnson PF, Mocchetti I. Synergistic effect of dexamethasone and beta-adrenergic receptor agonists on the nerve growth factor gene transcription. Brain Res Mol Brain Res 2004;124:97-104.
57. Subhedar NV, Shaw NJ. Dopamine versus dobutamine for hypotensive preterm infants. Cochrane Database Syst Rev 2003;3:CD001242.